|
|
|
|
|
|
| Series Offers Industry-Leading Insights into Key Issues in Clinical Development |
Raleigh, NC, May 16, 2013 - (ACN Newswire) - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced it will kick off its 2013 "Perspectives" webinar series June 18 with a session focused on clinical innovation. Designed to provide the latest insights on clinical research, the eight-session series will feature industry experts and INC Research thought leaders offering valuable insights and practical knowledge on a range of topics, including strategic data monitoring, site relationships and more.
"We're delighted to be continuing our Perspectives series with a host of new topics that examine key R&D issues," said Alistair Macdonald, Chief Operating Officer. "The interactive format of our webinars gives attendees the opportunity to gain valuable insight from top industry executives about the issues affecting them most along with real-world guidance they can apply to their clinical development efforts."
INC's June 18 session focuses on how innovative approaches to the R&D process are shaping the future of clinical research, and will be followed by two sessions in September on product lifecycle management and reducing site monitoring costs using a strategic approach. The Perspectives series also includes three sessions with a strong therapeutic and patient focus, including "Pediatric safety monitoring: Role of IRBs and DSMBs," "Pediatric patient/parent recruitment for rare disease indications" and "Recent results from large randomized trials in cardiovascular disease and implications for clinical practice." The 2013 Perspectives series concludes with a session in November exploring the complexities, challenges and best practices of conducting global clinical trials, and a session in early December sharing insights on the site/sponsor/CRO relationship dynamic and how companies are making these relationships more efficient and effective.
To view the full "Perspectives" schedule, register for the upcoming sessions, access the 2012 "Perspectives" archive or submit a topic for a future session, visit www.incresearch.com/perspectives .
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process(R) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media +1-513-345-1685
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
Topic: Press release summary
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
